Randomized Trial of Fetal Surgery for Severe Left Diaphragmatic Hernia COMMENT


Por: Deprest, JA, Nicolaides, KH, Benachi, A, Gratacós E, Ryan, G, Persico, N, Sago, H, Johnson, A, Wielgos, M, Berg, C, Van Calster, B and Russo, FM

Publicada: 1 dic 2021
Resumen:
Congenital diaphragmatic hernia (CDH) occurs in approximately 1 in 4000 births, and 85% of these cases have the defect on the left side. The condition is associated with neonatal death due to respiratory failure and pulmonary hypertension. For those who do survive, the condition may result in serious gastrointestinal and respiratory problems, orthopedic deformation, and delay in neurodevelopment. Fetoscopic endoluminal tracheal occlusion (FETO) is one technique that has been used in fetuses with severe hypoplasia due to CDH. In one study, FETO was shown to have an acceptable, maternal safety profile and to improve neonatal survival. However, there is a lack of data from randomized trials. The aim of this study was to evaluate the outcomes of FETO in fetuses with CDH on the left site compared with expectant prenatal care. This was an open-label, randomized, superiority trial conducted at centers with experience in FETO and other prenatal surgery in Belgium, the United Kingdom, France, Spain, Canada, Italy, Japan, the United States, Germany, the Netherlands, Switzerland, and Poland between February 2011 and March 2020. Included were adult women with singleton pregnancies, at <30 weeks' gestation, with severe CDH. Congenital diaphragmatic hernia cases were evaluated with a lung-to-head ratio (LHR), and those with an observed-to-expected LHR of 25% or less were included. Excluded were women who were not optimal candidates for fetal surgery, had an elevated risk of preterm birth, or would not be able to adhere to the protocol. The woman were randomized in a 1:1 ratio to either the FETO group or expectant care group. The primary outcome was survival to discharge from the neonatal intensive care unit. The trial was stopped early for efficacy after the third interimanalysis. A total of 80 women were included in the primary analysis, with 40 women in each group. More infants in the FETO group survived to discharge than in the expectant care group (40% vs 15%; relative risk [RR], 2.67; 95% confidence interval [CI], 1.22-6.11; P = 0.009). Likewise, more infants in the FETO group survived to 6 months (40% vs 15%; RR, 2.67; 95% CI, 1.22-6.11). The incidence of preterm, prelabor rupture of membranes was higher in the FETO group compared with the expectant group (47% vs 11%; RR, 4.51; 95% CI, 1.82-11.9). The incidence of preterm birth (<37 weeks' gestation) was also higher in the FETO group versus the expectant group (75% vs 29%; RR, 2.59; 95% CI, 1.59-4.52). Other adverse outcomes included 1 case of placental abruption in each group, 1 case of procedure-related placental laceration leading to neonatal death, and 1 case of neonatal death after an unsuccessful postnatal puncture at a non-FETO center. In a post hoc analysis of 11 women, including those who were randomized but their outcomes were not available at the third interim analysis, more infants survived to discharge in the FETO group than the expectant group (36% vs 14%; RR, 2.65; 95% CI, 1.21-6.09). In conclusion, a significant benefit was observed with the use of FETO in infants with severe CDH on the left side. This benefit was sustained through 6 months. Preterm, prelabor rupture of membranes and preterm births had increased odds of occurring in cases involving FETO.

Filiaciones:
Deprest, JA:
 Katholieke Univ Leuven, Dept Obstet & Gynecol, Leuven, Belgium

 Univ Hosp KU Leuven, Acad Dept Dev & Regenerat Biomed Sci, Leuven, Belgium

 Univ Coll London Hosp, Inst Womens Hlth, London, England

Nicolaides, KH:
 Kings Coll Hosp London, London, England

Benachi, A:
 Univ Paris Saclay, Hosp Antoine Beclere, Clamart, France

Gratacós E:
 Hosp Clin Barcelona, Barcelona, Spain

 St Joan de Deu, Barcelona, Spain

Ryan, G:
 Mt Sinai Hosp, Toronto, ON, Canada

Persico, N:
 Hosp Maggiore Policlin, Milan, Italy

Sago, H:
 Natl Ctr Child Hlth & Dev, Tokyo, Japan

Johnson, A:
 Childrens Mem Hermann Hosp, Houston, TX USA

Wielgos, M:
 Med Univ Warsaw, Warsaw, Poland

Berg, C:
 Univ Hosp Bonn, Bonn, Germany

Van Calster, B:
 Univ Hosp KU Leuven, Acad Dept Dev & Regenerat Biomed Sci, Leuven, Belgium

Russo, FM:
 Katholieke Univ Leuven, Dept Obstet & Gynecol, Leuven, Belgium

 Univ Hosp KU Leuven, Acad Dept Dev & Regenerat Biomed Sci, Leuven, Belgium
ISSN: 00297828





OBSTETRICAL & GYNECOLOGICAL SURVEY
Editorial
LIPPINCOTT WILLIAMS & WILKINS, TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103, Estados Unidos America
Tipo de documento: Editorial Material
Volumen: 76 Número: 12
Páginas: 724-725
WOS Id: 000734511500004
imagen Green Published

MÉTRICAS